Advertisement: Cambridge Network
Advertisement: Innova Systems
Advertisement: RSM
Advertisement: TTP
ARM Innovation Hub
Advertisement: Cambridge Corporate Finance Club
Advertisement: EBCam mid banner
Advertisement: Mogrify
Mid banner advertisement: BDO
Advertisement EY mid banner
RealVNC mid-banner general
RealVNC mid banner careers
Advertisement: Wild Knight Vodka
Barr Ellison Solicitors – commercial property
5 March, 2014 - 11:38 By News Desk

Cardiovascular R & D platform for preclinical drug development


A privately owned Hungarian SME is offering innovative and cost-effective preclinical R & D services focusing on cardiovascular diseases (e.g. infarction, heart failure, arrhythmias, sepsis) efficacy, safety, and pharmacokinetic animal models, including co-morbidity, custom designed and large animal models as well.

The company is looking for partners that are interested in out-sourcing their preclinical pharmacology projects. The company is open for joint venture or technical cooperation.

Closing date: 22/01/2015

Ref: TOHU20131210001

Add new comment

Newsletter Subscription

Stay informed of the latest news and features